ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J07CA06 | B | Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen(Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg, Tetanus toxoid (Prefilled syringe) - =40IU, Diphtheria toxoid (Prefilled syringe) - =30IU, H. Influenza type b polysaccharide(Vial) - 10mcg | 34 | 973379/01 | INFANRIX IPV + HIB | 1 x 0.5ml | Injectable dry powder+suspension | IM | Abela Frères S.A.L. | GlaxoSmithKline Biologicals SA | Belgium | 3,014,239 L.L | 23.08 | B | 2/5/2024 | 0 |